# Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit

> **NIH NIH UM1** · UNIVERSITY OF PENNSYLVANIA · 2020 · $299,668

## Abstract

ABSTRACT
The pandemic of COVID-19 has had and will continue to have a profound impact in the research operations of
the Philadelphia CTU and its associated CRSs (Therapeutic and Prevention)
The Aim of this supplemental request is to facilitate the return of safe and efficient clinical Research operations
at the Philadelphia CTU, critically affected by the COVID-19 epidemic.
We anticipate the following needs for our CTU from now until December 1st, 2020:
 1. Personnel. We anticipate needs of at least one Clinical Research Coordinator in both the Therapeutic
 and the Prevention CRS. This need is necessitated to maintain the clinical staff required to implement
 COVID-19 related clinical activities while regular HIV-related trials resume; and in order to minimize
 risks to workers among our current staff who are at higher risk for severe illness from COVID-19 who
 will require limited time “in office” and face-to-face exposure to clinical trial participants.
 2. Clinical supplies to ensure the safety of our employees and the clinical trial participants (Personal
 protective equipment, masks, gloves, face shields etc.). We are also anticipating that our institution will
 increase the requirement for COVID-19 testing of our personnel and our clinical trials participants.
 3. Increased personnel in the laboratory to allow it to remain operational in the case that one of our
 employees needs to be quarantined or falls sick in the following months.
 4. Equipment and testing kits for the clinical laboratory at the hospital of the University of
 Pennsylvania to ensure that the increased testing needs associated with our clinical research
 operations do not tax the regular clinical operations of the laboratory.

## Key facts

- **NIH application ID:** 10172693
- **Project number:** 3UM1AI069534-14S1
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** Ian Frank
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $299,668
- **Award type:** 3
- **Project period:** 2020-06-19 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10172693

## Citation

> US National Institutes of Health, RePORTER application 10172693, Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit (3UM1AI069534-14S1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10172693. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*